BIOA INVESTOR DEADLINE: BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
CASE ALLEGATIONS: BioAge Labs is a clinical-stage biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. In the IPO, BioAge Labs sold 12.65 million shares at ...
FRED’S TEAM RAISES OVER $8.5 MILLION FOR CANCER RESEARCH IN RECORD-BREAKING YEAR
Support from Fred’s Team is enabling medical oncologists like Sarat Chandarlapaty, MD, PhD, and his lab to investigate how cancer disrupts certain signaling pathways that regulate cell growth in the ...